AMSTERDAM, July 6, 2011 /PRNewswire/ --
Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
the field of human gene therapy, today announced the appointment of
Dr. Carlos R. Camozzi as Chief Medical Officer. Dr. Camozzi brings
to AMT more than 25 years of pharmaceutical industry ex